Theodore M Blum
Examiner (ID: 17120)
Most Active Art Unit | 2202 |
Art Unit(s) | 3642, 3662, 2604, 2200, 2603, 2202, 2607 |
Total Applications | 2205 |
Issued Applications | 1954 |
Pending Applications | 86 |
Abandoned Applications | 165 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18923378
[patent_doc_number] => 20240026382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => SMALL TYPE II-D CAS PROTEINS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/470189
[patent_app_country] => US
[patent_app_date] => 2023-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 170741
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18470189
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/470189 | SMALL TYPE II-D CAS PROTEINS AND METHODS OF USE THEREOF | Sep 18, 2023 | Pending |
Array
(
[id] => 18693020
[patent_doc_number] => 20230323401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => METHODS AND COMPOSITIONS FOR GENOME EDITING
[patent_app_type] => utility
[patent_app_number] => 18/148964
[patent_app_country] => US
[patent_app_date] => 2022-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58187
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18148964
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/148964 | METHODS AND COMPOSITIONS FOR GENOME EDITING | Dec 29, 2022 | Pending |
Array
(
[id] => 18483586
[patent_doc_number] => 20230210884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => Immunomodulating Gene Therapy
[patent_app_type] => utility
[patent_app_number] => 18/146999
[patent_app_country] => US
[patent_app_date] => 2022-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18146999
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/146999 | Immunomodulating Gene Therapy | Dec 26, 2022 | Pending |
Array
(
[id] => 18552398
[patent_doc_number] => 20230250407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => SILENCING OF DUX4 BY RECOMBINANT GENE EDITING COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 18/065255
[patent_app_country] => US
[patent_app_date] => 2022-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12279
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18065255
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/065255 | SILENCING OF DUX4 BY RECOMBINANT GENE EDITING COMPLEXES | Dec 12, 2022 | Pending |
Array
(
[id] => 18307750
[patent_doc_number] => 20230111650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => Lymphocyte-Based PKCe Test for Alzheimer's Disease
[patent_app_type] => utility
[patent_app_number] => 18/062642
[patent_app_country] => US
[patent_app_date] => 2022-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4221
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18062642
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/062642 | Lymphocyte-Based PKCe Test for Alzheimer's Disease | Dec 6, 2022 | Pending |
Array
(
[id] => 18784866
[patent_doc_number] => 20230372544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => OPTIMIZED CLN1 GENES AND EXPRESSION CASSETTES AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 18/052082
[patent_app_country] => US
[patent_app_date] => 2022-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15460
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18052082
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/052082 | OPTIMIZED CLN1 GENES AND EXPRESSION CASSETTES AND THEIR USE | Nov 1, 2022 | Pending |
Array
(
[id] => 18221667
[patent_doc_number] => 20230060661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => TISSUE-SPECIFICALLY EXPRESSED CIRCULAR RNA MOLECULE AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/818835
[patent_app_country] => US
[patent_app_date] => 2022-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18520
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17818835
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/818835 | TISSUE-SPECIFICALLY EXPRESSED CIRCULAR RNA MOLECULE AND APPLICATION THEREOF | Aug 9, 2022 | Pending |
Array
(
[id] => 18064499
[patent_doc_number] => 20220395586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => ENHANCED DELIVERY OF VIRAL PARTICLES TO THE STRIATUM AND CORTEX
[patent_app_type] => utility
[patent_app_number] => 17/816139
[patent_app_country] => US
[patent_app_date] => 2022-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34698
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17816139
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/816139 | ENHANCED DELIVERY OF VIRAL PARTICLES TO THE STRIATUM AND CORTEX | Jul 28, 2022 | Pending |
Array
(
[id] => 18361140
[patent_doc_number] => 20230142731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => COMPOSITIONS AND METHODS FOR INCREASING OR ENHANCING TRANSDUCTION OF GENE THERAPY VECTORS AND FOR REMOVING OR REDUCING IMMUNOGLOBULINS
[patent_app_type] => utility
[patent_app_number] => 17/862622
[patent_app_country] => US
[patent_app_date] => 2022-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38243
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17862622
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/862622 | COMPOSITIONS AND METHODS FOR INCREASING OR ENHANCING TRANSDUCTION OF GENE THERAPY VECTORS AND FOR REMOVING OR REDUCING IMMUNOGLOBULINS | Jul 11, 2022 | Pending |
Array
(
[id] => 18077767
[patent_doc_number] => 20220403379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => COMPOSITIONS AND METHODS FOR TARGETED DELIVERY OF CRISPR-CAS EFFECTOR POLYPEPTIDES AND TRANSGENES
[patent_app_type] => utility
[patent_app_number] => 17/824626
[patent_app_country] => US
[patent_app_date] => 2022-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17824626
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/824626 | COMPOSITIONS AND METHODS FOR TARGETED DELIVERY OF CRISPR-CAS EFFECTOR POLYPEPTIDES AND TRANSGENES | May 24, 2022 | Pending |
Array
(
[id] => 17852240
[patent_doc_number] => 20220282282
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => BUFFER SOLUTIONS FOR ELECTROPORATION
[patent_app_type] => utility
[patent_app_number] => 17/682793
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21801
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17682793
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/682793 | BUFFER SOLUTIONS FOR ELECTROPORATION | Feb 27, 2022 | Pending |
Array
(
[id] => 17719155
[patent_doc_number] => 20220211874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES
[patent_app_type] => utility
[patent_app_number] => 17/591563
[patent_app_country] => US
[patent_app_date] => 2022-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51006
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17591563
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/591563 | MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES | Feb 1, 2022 | Pending |
Array
(
[id] => 17503476
[patent_doc_number] => 20220096578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => COMPOSITIONS AND METHODS OF USING STAT1/3 INHIBITORS WITH ONCOLYTIC HERPES VIRUS
[patent_app_type] => utility
[patent_app_number] => 17/496637
[patent_app_country] => US
[patent_app_date] => 2021-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11813
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17496637
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/496637 | COMPOSITIONS AND METHODS OF USING STAT1/3 INHIBITORS WITH ONCOLYTIC HERPES VIRUS | Oct 6, 2021 | Pending |
Array
(
[id] => 18077772
[patent_doc_number] => 20220403384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => ENGINEERED CIRCULAR RNA CIRCMIR-29B AND USE THEREOF IN PREPARATION OF MEDICINE FOR TREATING MUSCLE ATROPHY
[patent_app_type] => utility
[patent_app_number] => 17/492465
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7520
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17492465
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/492465 | ENGINEERED CIRCULAR RNA CIRCMIR-29B AND USE THEREOF IN PREPARATION OF MEDICINE FOR TREATING MUSCLE ATROPHY | Sep 30, 2021 | Pending |
Array
(
[id] => 17472664
[patent_doc_number] => 20220080168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => VAGINAL REJUVENATION METHODS AND DEVICES
[patent_app_type] => utility
[patent_app_number] => 17/484479
[patent_app_country] => US
[patent_app_date] => 2021-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4172
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17484479
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/484479 | VAGINAL REJUVENATION METHODS AND DEVICES | Sep 23, 2021 | Pending |
Array
(
[id] => 17297843
[patent_doc_number] => 20210393682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => METHOD OF MODIFYING MACROPHAGE DIFFERENTIATION AND IMMUNITY
[patent_app_type] => utility
[patent_app_number] => 17/465266
[patent_app_country] => US
[patent_app_date] => 2021-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5568
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17465266
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/465266 | METHOD OF MODIFYING MACROPHAGE DIFFERENTIATION AND IMMUNITY | Sep 1, 2021 | Abandoned |
Array
(
[id] => 17258895
[patent_doc_number] => 20210371880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => RECOMBINANT ADENO-ASSOCIATED VECTORS
[patent_app_type] => utility
[patent_app_number] => 17/400768
[patent_app_country] => US
[patent_app_date] => 2021-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8435
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17400768
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/400768 | RECOMBINANT ADENO-ASSOCIATED VECTORS | Aug 11, 2021 | Abandoned |
Array
(
[id] => 17480443
[patent_doc_number] => 20220087947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => NANOPARTICLE FOR DELIVERING RIBONUCLEOPROTEIN AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/384913
[patent_app_country] => US
[patent_app_date] => 2021-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10797
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17384913
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/384913 | NANOPARTICLE FOR DELIVERING RIBONUCLEOPROTEIN AND USE THEREOF | Jul 25, 2021 | Pending |
Array
(
[id] => 17386003
[patent_doc_number] => 20220033855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => ARRAYED NUCLEIC ACID-GUIDED NUCLEASE OR NICKASE FUSION EDITING
[patent_app_type] => utility
[patent_app_number] => 17/384770
[patent_app_country] => US
[patent_app_date] => 2021-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11239
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17384770
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/384770 | ARRAYED NUCLEIC ACID-GUIDED NUCLEASE OR NICKASE FUSION EDITING | Jul 24, 2021 | Abandoned |
Array
(
[id] => 17183932
[patent_doc_number] => 20210330817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => SYNTHETIC DNA VECTORS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/365805
[patent_app_country] => US
[patent_app_date] => 2021-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45520
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17365805
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/365805 | SYNTHETIC DNA VECTORS AND METHODS OF USE | Jun 30, 2021 | Abandoned |